Skip to main content
Clinical Trials/EUCTR2010-019647-19-GB
EUCTR2010-019647-19-GB
Active, not recruiting
Not Applicable

A double blind randomised placebo controlled trial of montelukast in the treatment of acute persistent cough in young people and adults (aged 16-49) in primary care - Montelukast for persistent cough in young people and adults

niversity of Oxford0 sites260 target enrollmentDecember 22, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute persistent cough with no established diagnosis
Sponsor
niversity of Oxford
Enrollment
260
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 22, 2010
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\)Male or Female, aged 16 years to 49 years inclusive.
  • 2\)Presenting with a persistent cough of 2\-8 weeks' duration without an established diagnosis (e.g. asthma, gastro\-oesophageal reflux).
  • 3\)Able to complete cough diary and study questionnaires.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • The participant may not enter the study if ANY of the following apply:
  • 1\)There is a contraindication to montelukast
  • 2\)Chronic severe disease which may cause persistent cough (eg cystic fibrosis, bronchiectasis, cardiac failure)
  • 3\)Immunodeficiency/immunocompromised state
  • 4\)Pregnancy
  • 5\)Breastfeeding
  • 6\)Current smoker (i.e. stopped smoking less than 6 months ago).
  • 7\)Regular medication associated with persistent cough (ACE inhibitors)
  • 8\)The individual is in another clinical research study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A double blind randomised placebo controlled trial to compare two doses of a mineral supplement and a herbomineral combination in alleviating the symptoms of osteoarthritis of the knee
ISRCTN38432711Vedic Lifesciences (India)107
Completed
Not Applicable
A double blind randomised placebo-controlled trial to compare the effectiveness of paracervical block plus Intrauterine anesthesia and paracervical block alone for pain relief during fractional durettageocal anesthesia for fractional curettageSurgeryFractional curettage
ISRCTN02384619Mahidol University - Siriraj Grant for Research Development (Thailand)70
Completed
Not Applicable
A double blind randomised placebo-controlled trial of amoxycillin and budesonide in patients with acute rhinosinusitis in general practiceEar, nose and throat diseases: Ear, nose and throat diseasesEar, Nose and ThroatAcute rhinosinusitis
ISRCTN84277311HS R&D Regional Programme Register - Department of Health (UK)240
Completed
Phase 3
A trial comparing two treatment shortening regimens with the standard anti tuberculosis treatment regimen for the treatment of adults with pulmonary tuberculosisHealth Condition 1: null- Treatment naive Tuberculosis patient
CTRI/2011/05/001745Apothecaries Private limited1,900
Completed
Not Applicable
A randomised double blind placebo controlled trial of the addition of metformin to optimal treatment in patients with chronic heart failure. Assessment by regional haemodynamics neurohumoral activation and symptomatic well beingCardiovascular: Congestive heart failure (CHF)Circulatory SystemHeart failure
ISRCTN22334267Department of Health (UK)20